A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback